KAAREN R OLESEN

Allopathic & Osteopathic Physicians|Obstetrics & Gynecology URBANDALE, IA NPI 1013983881

General Payments — all program years on this page

$5,109.31

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 107
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $470.13 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $371.1319
Education $99.001

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $202.8813
2019 $256.9914
2020 $135.575
2021 $436.1817
2022 $3,152.4222
2023 $455.1416
2024 $470.1320

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086206870 Bayer Healthcare Pharmaceuticals Inc. $13.11 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104626492 AstraZeneca Pharmaceuticals LP $13.61 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105151597 ABBVIE INC. $27.37 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105151599 ABBVIE INC. $17.24 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105151601 ABBVIE INC. $33.04 03/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105151603 ABBVIE INC. $28.05 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105555064 AstraZeneca Pharmaceuticals LP $14.59 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105658236 AstraZeneca Pharmaceuticals LP $19.99 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135093543 Lilly USA, LLC $21.20 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139322352 Astellas Pharma US Inc $17.47 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139370033 Astellas Pharma US Inc $20.68 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139376878 Astellas Pharma US Inc $18.42 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139412391 Astellas Pharma US Inc $17.27 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139436666 Astellas Pharma US Inc $20.60 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139446582 Astellas Pharma US Inc $99.00 12/05/2024 Education Undisputed 01/23/2026 View at CMS
1141587756 Merck Sharp & Dohme LLC $14.97 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141833093 Merck Sharp & Dohme LLC $22.19 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141953279 Merck Sharp & Dohme LLC $13.64 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151672845 Teva Pharmaceuticals USA, Inc. $24.15 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153654800 Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.54 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.